Compositions comprising epothilones and their use for the treatment of carcinoid syndrome

Details for Australian Patent Application No. 2002366531 (hide)

Owner Novartis AG

Inventors Rothermel, John David; Rubin, Eric Howard

Agent Davies Collison Cave

Pub. Number AU-B-2002366531

PCT Number PCT/EP02/14162

PCT Pub. Number WO2003/049734

Priority 60/342,167 13.12.01 US; 60/415,990 04.10.02 US

Filing date 12 December 2002

Wipo publication date 23 June 2003

Acceptance publication date 22 February 2007

International Classifications

A61J 1/14 (2006.01) Containers specially adapted for medical or pharmaceutical purposes - Details

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 31/7008 (2006.01) - Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine

A61K 31/704 (2006.01)

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 493/04 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

Event Publications

28 August 2003 Application Open to Public Inspection

  Published as AU-B-2002366531

28 August 2003 Complete Application Filed

  Priority application(s): 60/342,167 13.12.01 US; 60/415,990 04.10.02 US

22 February 2007 Application Accepted

  Published as AU-B-2002366531

21 June 2007 Standard Patent Sealed

7 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002366532-IN VITRO PRODUCTION OF DENDRITIC CELLS FROM CD14+ MONOCYTES, ESPECIALLY FOR THE PREPARATION OF SUSPENSION, MONOLAYER AND THREE-DIMENSIONAL CELL AND/OR TISSUE MODELS, AND USE OF THESE MODELS

2002366530-UTILIZATION OF DIHYDROPINOSYLVIN AND DERIVATIVES THEREOF AS TYROSINASE INHIBITORS FOR SKIN LIGHTENING OR AS ANTIMICROBIAL SUBSTANCES FOR PRESERVATION OR FOR THE TREATMENT OF ACNE, DANDRUFF OR BODY ODORS